Subtype
Malignant Urinary Tract Neoplasm
CI-CAN-00003252Explore in graph →
507 active trials14 approved drugs29 evidence items
- NCIt
- C192668
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003252Explore in graph →
Clinical trials
1,954 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (246)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04018053 | 18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy | completed | Early Phase 1 | 16 | Brigham and Women's HospitalOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT01868087 | Impact Advanced Recovery® for Radical Cystectomy (RC) Patients: a Pilot Study | completed | Early Phase 1 | 30 | Jill Hamilton-Reeves, PhD RD LDOTHER | 1 | Apr 15, 2026 | clinicaltrials |
| NCT04897763 | Assessment of Safety, Tolerability, Radiation Dosimetry, Imaging Properties of 89Zr-girentuximab in Patients With NMIBC(PERTINENCE) | completed | Early Phase 1 | 6 | Institut Cancerologie de l'OuestOTHER | 1 | Jan 7, 2026 | clinicaltrials |
| NCT03039413 | Copper Cu-64 TP3805 PET/CT in Imaging Patients With Urothelial Cancer Undergoing Surgery or Biopsy | completed | Early Phase 1 | 20 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | Aug 22, 2025 | clinicaltrials |
| NCT03473730 | Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer | completed | Early Phase 1 | 17 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 30, 2025 | clinicaltrials |
| NCT03071328 | INJECT: A Pilot Study of Intra-tumoral Injections in Metastatic Urological Cancers | completed | Early Phase 1 | 10 | Duke UniversityOTHER | 1 | Apr 11, 2022 | clinicaltrials |
| NCT01738815 | Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder Cancer | completed | Early Phase 1 | 43 | State University of New York - Upstate Medical UniversityOTHER | 1 | Oct 22, 2021 | clinicaltrials |
| NCT02753309 | A Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder Cancer | completed | Early Phase 1 | 33 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Mar 19, 2021 | clinicaltrials |
| NCT02646319 | Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations | completed | Early Phase 1 | 2 | Mayo ClinicOTHER | 1 | Jun 6, 2019 | clinicaltrials |
| NCT02326168 | PRIME: Pilot Study Evaluating Percutaneous Vaccination of BCG for Bladder Cancer | completed | Early Phase 1 | 25 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jan 25, 2017 | clinicaltrials |
| NCT02505516 | BLADDER CANCER SCREENING AMONG DIABETIC PATIENTS | completed | Early Phase 1 | 150 | UFUOMA MILLER FAKPOROTHER | 1 | Jul 22, 2015 | clinicaltrials |
| NCT00734994 | Mitomycin C With Hyperthermia and Intravesical Mitomycin C to Treat Recurrent Bladder Cancer | completed | Early Phase 1 | 15 | Mark DewhirstOTHER | 1 | Jun 29, 2015 | clinicaltrials |
| NCT02139371 | Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography | completed | Early Phase 1 | 10 | Rigshospitalet, DenmarkOTHER | 1 | Dec 12, 2014 | clinicaltrials |
| NCT01240824 | Study of BCG + Aminophylline Toxicity When Used in the Treatment of Bladder Cancer(BCG) | completed | Early Phase 1 | 3 | University of VirginiaOTHER | 1 | Apr 14, 2014 | clinicaltrials |
Data updated 22 days agoSource updated Jun 24, 2026source: clinicaltrials